Nolicin (Norfloxacin)

Norfloxacin, the active ingredient in Nolicin, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It is employed to treat bacterial infections of the urinary tract, prostate and gastrointestinal system in adult patients and is prescribed by qualified healthcare professionals.

GNH USA supplies Nolicin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance. The company maintains rigorous batch testing, stable storage conditions, and on‑time delivery to meet global health needs.

Norfloxacin is a fluoroquinolone antibacterial used to treat infections of specific organ systems.

Urinary tract infections: eliminates susceptible uropathogenic bacteria, alleviating dysuria, frequency, urgency, and preventing progression to pyelonephritis or recurrent infections, thereby restoring normal urinary function. Prostatitis: penetrates prostatic tissue to eradicate causative organisms, reducing inflammation, decreasing pelvic pain, improving urinary flow, and aiding resolution of chronic bacterial prostatitis. Gastrointestinal infections: targets Gram‑negative and some Gram‑positive pathogens in the gut, relieving diarrhea, abdominal cramps, fever, and preventing systemic spread of infection.

Norfloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring early in therapy. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis following intestinal flora disruption.

Before prescribing norfloxacin, clinicians should evaluate patient risk factors and monitor for specific safety concerns. - Assess renal function: dose adjustment may be required in impaired clearance. - Review allergy history: avoid in patients with known hypersensitivity to fluoroquinolones. - Caution in elderly: increased risk of tendon disorders and CNS effects. - Avoid concomitant use with tizanidine: may cause severe hypotension. - Monitor for tendon pain: discontinue if symptoms of tendonitis appear. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Norfloxacin can interact with several medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Tizanidine: may cause profound hypotension and sedation. - Corticosteroids: combined use raises risk of tendon rupture. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Antacids or metal‑containing supplements: reduce norfloxacin absorption, separate dosing by at least 2 hours. - NSAIDs: may enhance central nervous system stimulation, leading to dizziness or seizures.